SEGMENT AND GEOGRAPHIC INFORMATION

The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.

•

The Specialty Surgical Solutions segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.


•	The Orthopedics and Tissue Technologies segment includes such offerings as skin repair, advanced wound care, amniotic tissue, bone and joint fixation implants in the upper and lower extremities, bone grafts and nerve and tendon repair.

The Corporate and other category includes (i) various legal, finance, information systems, executive, and human resource functions, (ii) brand management, and (iii) share-based compensation costs.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the three and six months ended June 30, 2017 and 2016 are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
	2017			2016			2017		2016
	(In thousands)
Segment Net Sales
Specialty Surgical Solutions	$	159,857		$	158,163		$	316,147	$	309,338
Orthopedics and Tissue Technologies	122,307			91,146			224,654		176,741
Total revenues	$	282,164		$	249,309		$	540,801	$	486,079
Segment Profit
Specialty Surgical Solutions	$	67,250		$	63,397		$	129,953	$	120,978
Orthopedics and Tissue Technologies	31,010			26,025			58,089		46,300
Segment profit	98,260			89,422			188,042		167,278
Amortization	(5,419		)	(3,471)			(9,520)		(6,943)
Corporate and other	(75,856		)	(63,574		)	(151,577)		(115,859		)
Operating income	$	16,985		$	22,377		$	26,945	$	44,476

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:



	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
	(In thousands)
United States	$	219,266	$	191,872	$	420,363	$	373,101
Europe	32,499		31,663		61,315		61,098
Rest of World	30,399		25,774		59,123		51,880
Total Revenues	$	282,164	$	249,309	$	540,801	$	486,079